Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic

Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic

Immune checkpoint inhibitors (ICIs) have improved survival in patients affected by several solid tumours at the cost of new autoimmune adverse events. Endocrine toxicity is frequently reported in patients treated with these agents, mainly as thyroid dysfunction and hypophysitis. Primary adrenal insu...

Full description

Bibliographic Details
Main Authors: Agnese Barnabei, Paola Senes, Alessandro Scoppola, Alfonsina Chiefari, Giovanni Maria Iannantuono, Marialuisa Appetecchia, Francesco Torino
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
primary adrenal insufficiency
endocrine toxicity
immune checkpoint inhibitors
anticancer drugs
Online Access:https://www.mdpi.com/2072-6694/14/3/593

Internet

https://www.mdpi.com/2072-6694/14/3/593

Similar Items